ARCHIVED: NOT AVAILABLE FOR CREDIT
Healthcare Delivery Reform and the Affordable Care Act: Current Status and Implications for Pathology and Laboratory Medicine
The Affordable Care Act (ACA) of 2010 is the most significant healthcare and social policy legislation since the Social Security Act of 1935 and the Medicare Act of 1965. The ACA represents the culmination of many years’ work and several presidents who considered legislating or attempted to legislate healthcare reform in the United States. The ACA has the potential to drastically change the way healthcare is delivered, and, as is the case for every other medical specialty, pathology and laboratory medicine have been and will continue to be impacted by this law.
Originally presented December 12, 2013 in Salt Lake City, Utah.
Ronald L. Weiss, MD, MBA
Staff Hematopathologist, ARUP Laboratories
Professor of Pathology, University of Utah School of Medicine
Dr. Weiss served as ARUP’s chief medical officer and director of laboratories from 1993 until 2002, director of business development from 2002 until 2003, president and chief operating officer from 2003 until 2009, and executive vice president from 2009 until 2010. Dr. Weiss is a professor of pathology at the University of Utah and is board certified in anatomic/clinical pathology, microbiology, and hematology by the American Board of Pathology. Dr. Weiss is past chairman of the board of the American Clinical Laboratory Association and past president of the American Pathology Foundation. He is a fellow of the College of American Pathologists and the American Society of Clinical Pathologists. Dr. Weiss received his MD from Creighton University and an MBA from the University of Utah, where he completed his residency training.
After this presentation, participants will be able to:
- Provide a brief historical overview of health care reform initiatives.
- Review the ACA, its current status and future implementation.
- Identify the pathology and laboratory medicine-centric components of the ACA.
- Review additional policy and legislative initiatives that affect pathology and lab medicine.
University of Utah School of Medicine, University of Utah Department of Pathology, and ARUP Laboratories